This Biotech Stock Is Up 50% in 2025, But Redditors Say It Has More Upside – Here’s Why

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is 1 of the champion small-cap stocks with immense upside imaginable according to Redditors. The institution is moving connected oncology therapies designed to people the tumor microenvironment. The institution precocious announced to get Elektrofi, which tin grow its cause transportation capabilities into high-concentration biologic formulations. The banal has gained astir 54% truthful acold this year.

The FDA precocious approved Darzalex Faspro, an injectable mentation of the aggregate myeloma therapy daratumumab, developed by J&J and Halozyme Therapeutics (HALO). The merchandise was approved arsenic a front-line enactment for airy concatenation (AL) amyloidosis, a uncommon humor compartment disorder.

Earlier successful November, the institution posted beardown quarterly results, indicating gross maturation of 22% twelvemonth implicit year, portion royalty gross accrued 52%.

Artisan Small Cap Fund stated the pursuing regarding Halozyme Therapeutics, Inc. (NASDAQ:HALO) successful its second 4th 2025 capitalist letter:

“Among the detractors successful Q2 were Halozyme Therapeutics, Inc. (NASDAQ:HALO), Clearwater Analytics and Lattice Semiconductor. Halozyme provides a unsocial exertion level (ENHANZE®) that converts biologics and tiny molecule drugs administered intravenously into a subcutaneous formulation. The institution reported beardown net and raised its full-year guidance successful May, but shares were negatively impacted by uncertainty surrounding caller draught guidance from the Centers for Medicare and Medicaid Services (CMS) connected cause pricing and imaginable delays successful launching caller products. We trimmed our presumption arsenic we await last guidance from CMS.”

While we admit the imaginable of HALO arsenic an investment, our condemnation lies successful the content that immoderate AI stocks clasp greater committedness for delivering higher returns and person constricted downside risk. If you are looking for an highly inexpensive AI banal that is besides a large beneficiary of Trump tariffs and onshoring, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.